Finance

Lists
524703:BOM
Sandu Pharmaceuticals Ltd
₹35.66
+1.60%
(+0.56) 1D
Oct 16, 3:52:26 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524703...
Open
₹35.49
High
₹36.39
Low
₹35.49
Mkt. cap
344.51M
Avg. vol.
2.20K
Volume
1.24K
Dividend
2.80%
Quarterly dividend
₹0.25
Ex-dividend date
Sep 4, 2026
P/E ratio
18.15
52-wk high
₹50.00
52-wk low
₹30.00
EPS
₹1.97
No. of employees
258
Open
₹35.49
High
₹36.39
Low
₹35.49
Mkt. cap
344.51M
Avg. vol.
2.20K
Volume
1.24K
Dividend
2.80%
Quarterly dividend
₹0.25
Ex-dividend date
Sep 4, 2026
P/E ratio
18.15
52-wk high
₹50.00
52-wk low
₹30.00
EPS
₹1.97
No. of employees
258
News stories
From web sources and news partners
About Sandu Pharmaceuticals Ltd
CEO-
Employees258
Founded1899
Headquarters-
SectorPersonal care products
Websitesandu.in
Last report
Aug 11, 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
163.89M / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
176.21M
187.61M
168.53M
163.89M
Cost of goods sold
83.27M
78.87M
85.77M
65.40M
Cost of revenue
83.27M
78.87M
85.77M
65.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.38M
26.46M
122.83M
27.94M
Operating expense
86.01M
99.99M
78.68M
94.76M
Total operating expenses
169.28M
178.86M
164.46M
160.16M
Operating income
6.93M
8.75M
4.08M
3.73M
Other non operating income
480.00K
137.00K
-837.00K
174.00K
EBT including unusual items
7.15M
8.55M
7.47M
3.60M
EBT excluding unusual items
7.15M
8.55M
7.47M
3.60M
Income tax expense
1.90M
-1.20M
7.04M
1.32M
Effective tax rate
26.63%
-14.05%
94.18%
36.70%
Other operating expenses
57.94M
71.87M
-45.80M
65.18M
Net income
5.24M
9.75M
435.00K
2.28M
Net profit margin
2.98%
5.20%
0.26%
1.39%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4.44M
-
Interest expense
-266.00K
-335.00K
-212.00K
-299.00K
Net interest expenses
-266.00K
-335.00K
4.23M
-299.00K
Depreciation and amortization charges
1.69M
1.66M
1.65M
1.64M
EBITDA
8.66M
9.86M
5.18M
5.42M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps